[헬스코리아뉴스] The Green Cross' sales of 2009 have recorded 634.2 billion won.
Green Cross, a major Korean drugmaker announced by fair disclosure, on 27 January, that its sales of 2009 have recorded 634.2 billion won, up 24.6% compared with 2008.
Net profit has recorded 80,5 billion won, up 64.8% and operating profit 119.4 billion won, up 75.8% compared with 2008.
Green Cross analyzed that this good sales record was thanks to its own developed new flu vaccine and to the growth in the export sector of blood components.
[관련 기사]
◆ 녹십자 2009 매출액 6432억 달성 … 전년 대비 24.6%↑